GLPBio

Innate Immunity

Products Related to Innate Immunity(566)

  • GC40910 structure
    GC409101-Oleoyl-2-hydroxy-sn-glycero-3-PE
    CAS: 89576-29-4
    Purity: >99.00%

    1-Oleoyl-2-hydroxy-sn-glycero-3-PE is a naturally-occurring lysophospholipid and an analog of plasmalogen lysophosphatidylethanolamine.

  • GC40922 structure
    GC40922SRS11-92
    CAS: 1467047-25-1
    Purity: >98.00%

    Ferrostatin-1(Fer-1) 유사체인 SRS11-92는 강력한 ferroptosis 억제제입니다.

  • GC40971 structure
    GC4097110(S),17(S)-DiHDHA
    CAS: 871826-47-0
    Purity: >98.00%

    10(S),17(S)-DiHDHA(신경 조직에서 생성될 때 뉴로프로텍틴 D1이라고도 함)는 DHA에서 파생된 디하이드록시 지방산으로 강력한 보호 및 항염 활성을 나타냅니다.

  • GC40975 structure
    GC4097517(S)-HpDHA
    CAS: 123673-33-6
    Purity: >98.00%

    17(S)-HpDHA is a mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, human glial cells, and mouse brain.

  • GC40980 structure
    GC40980Maresin 2
    CAS: 1639809-46-3
    Purity: ≥95.00%

    Maresin 2는 인간 대식세포의 항염증제 및 분해 촉진 매개체입니다.

  • GC40981 structure
    GC40981Protectin D1
    CAS: 660430-03-5
    Purity: >98.00%

    프로텍틴 D1, 신경 세포에 의해 생성될 때 신경 프로텍틴 D1은 도코사헥사엔산에서 생성되는 새로운 생리 활성 제품 계열의 구성원입니다.

  • GC40982 structure
    GC40982Resolvin D5
    CAS: 578008-43-2
    Purity: >95.00%

    Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid.

  • GC41096 structure
    GC4109612-oxo Leukotriene B4
    CAS: 136696-10-1
    Purity: >90.00%

    Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from arachidonic acid through the 5-LO pathway.

  • GC41100 structure
    GC4110014,15-dehydro Leukotriene B4
    CAS: 114616-11-4
    Purity: >97.00%

    Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from arachidonic acid through the 5-lipoxygenase pathway.

  • GC41102 structure
    GC4110215-deoxy-δ12,14-Prostaglandin D2
    CAS: 85235-11-6
    Purity: >95.00%

    15-deoxy-δ12,14-PGD2 is a synthetic analog of PGD2 and a potential precursor to the PPARγ ligand 15-deoxy-δ12,14-PGJ2.

  • GC41107 structure
    GC41107Leukotriene B5
    CAS: 80445-66-5
    Purity: >98.00%

    Leukotriene B5 (LTB5) is a leukotriene with diverse biological activities.

  • GC41123 structure
    GC4112312-epi Leukotriene B4
    CAS: 83709-73-3
    Purity: >97.00%

    Leukotriene B4 (LTB4) compounds are produced by both enzymatic and non-enzymatic processes.

  • GC41126 structure
    GC411265(S),12(S)-DiHETE
    CAS: 79056-01-2
    Purity: >98.00%

    5(S),12(S)-DiHETE is a natural bioactive lipid derived from arachidonic acid.

  • GC41127 structure
    GC411275(S),15(S)-DiHETE
    CAS: 82200-87-1
    Purity: >98.00%

    5(S),15(S)-DiHETE는 \5(S),15(S)-DiHETE is an “activated” intermediate, inhibits platelet aggregation with an IC50 of 1.3 μM.en_ko_2021q1.md

  • GC41136 structure
    GC411368(S),15(S)-DiHETE
    CAS: 80234-65-7
    Purity: >98.00%

    8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidation by 15-LO.

  • GC41144 structure
    GC4114411-trans Leukotriene C4
    CAS: 74841-69-3
    Purity: >97.00%

    11-trans Leukotriene C4 (11-trans LTC4) is a C-11 double bond isomer of LTC4.

  • GC41145 structure
    GC4114514,15-Leukotriene C4
    CAS: 75290-60-7
    Purity: >95.00%

    Leukotrienes (LTs) are a group of acute inflammatory mediators derived from arachidonic acid in leukocytes.

  • GC41148 structure
    GC4114814,15-Leukotriene D4
    CAS: 75290-64-1
    Purity: >97.00%

    14,15-Leukotriene D4 (14,15-LTD4) is a member of an alternate class of LTs synthesized by a pathway involving the dual actions of 15- and 12-lipoxygenases (15- and 12-LOs) on arachidonic acid via 15-HpETE and 14,15-LTA4 intermediates.

  • GC41150 structure
    GC4115014,15-Leukotriene E4
    CAS: 1000852-57-2
    Purity: >97.00%

    Leukotrienes (LTs) are a group of acute inflammatory mediators derived from arachidonic acid in leukocytes.

  • GC41160 structure
    GC411601a,1b-dihomo Prostaglandin E2
    CAS: 26198-80-1
    Purity: >98.00%

    1a,1b-dihomo Prostaglandin E2 (PGE2) is a rare polyunsaturated fatty acid first identified in extracts of sheep vesicular gland microsomes, known to contain COX, incubated with adrenic acid.

  • GC41164 structure
    GC4116415(R)-15-methyl Prostaglandin D2
    CAS: 210978-26-0
    Purity: >95.00%

    15(R)-15-methyl Prostaglandin D2 (15(R)-15-methyl PGD2) is a metabolically stable synthetic analog of PGD2.

  • GC41169 structure
    GC41169Lipoxin B4 methyl ester
    CAS: 97589-07-6
    Purity: >95.00%

    Lipoxin B4 (LXB4) methyl ester is a lipid soluble prodrug form of the transcellular metabolite LXB4.

  • GC41170 structure
    GC41170Prostaglandin D2 methyl ester
    CAS: 49852-81-5
    Purity: >97.00%

    Prostaglandin D2 (PGD2) is the major eicosanoid product of mast cells and is produced in large quantities by hematopoietic PGD synthase during allergic and asthmatic anaphylaxis.

  • GC41189 structure
    GC41189Ricinelaidic Acid
    CAS: 540-12-5
    Purity: >98.00%

    Ricinelaidic acid is a 12-hydroxy fatty acid and an antagonist of leukotriene B4 (LTB4) receptors (Ki = 2 μM in porcine neutrophil membranes).